𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Long-term mycophenolate mofetil treatment in pediatric renal transplant patients

✍ Scribed by John P. Roberts; Donald Potter; M. René Bouw

Publisher
Wiley (John Wiley & Sons)
Year
2009
Tongue
English
Weight
86 KB
Volume
38
Category
Article
ISSN
0090-2934

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Long-term outcome of mycophenolate mofet
Long-term outcome of mycophenolate mofetil rescue therapy for resistant acute allograft rejection in pediatric liver transplant recipients
✍ Marion Margaret Aw; Anita Verma; Mohamed Rela; Nigel Heaton; Giorgina Mieli-Verg 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 88 KB 👁 1 views

Mycophenolate mofetil (MMF) has been used to rescue liver allografts with steroid-resistant rejection (SRR). However, the long-term outcome of these patients is not known. This study evaluates the long-term outcome of MMF rescue therapy for SRR in pediatric liver allograft recipients. Twenty-six chi

Long-term effects of calcineurin inhibit
Long-term effects of calcineurin inhibitor conversion to mycophenolate mofetil on renal function after liver transplantation
✍ Caroline Créput; Frederique Blandin; Benjamin Deroure; Bruno Roche; Faouzi Salib 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 123 KB 👁 1 views

Calcineurin inhibitors (CNIs) are the cornerstone of immunosuppression after liver transplantation. However, CNI treatment is frequently associated with chronic renal failure (CRF). The reduction or interruption of CNI may reduce renal failure. We prospectively studied 49 liver recipients treated wi

A combination study design to examine my
A combination study design to examine mycophenolate mofetil (MMF) and PTLD in renal transplant patients
✍ Hilal Maradit Kremers; Donnie P. Funch; Richard A. Robson; Michael A. Nalesnik; 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 117 KB

Renal transplant recipients who are chronically immunosuppressed by drugs are at a higher risk of developing malignancies. Commonly observed malignancies are several forms of posttransplant lymphoproliferative disorders (PTLD), skin, lip and gynaecological cancers. The risk is associated with many r

Mycophenolate mofetil combination therap
Mycophenolate mofetil combination therapy improves long-term outcomes after liver transplantation in patients with and without hepatitis C
✍ Russell H. Wiesner; Jolene S. Shorr; Bettina J. Steffen; Alice H. Chu; Robert D. 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 121 KB

To evaluate the impact of mycophenolate mofetil (MMF) on long-term outcomes of tacrolimus and corticosteroids, we analyzed data reported to the Scientific Registry of Transplant Recipients for 11,670 adult patients (3463 with hepatitis C [HCV]) who underwent primary, single-organ, liver transplantat

Long-term renal function in liver transp
Long-term renal function in liver transplant recipients and impact of immunosuppressive regimens (calcineurin inhibitors alone or in combination with mycophenolate mofetil): The TRY study
✍ Svetlana Karie-Guigues; Nicolas Janus; Faouzi Saliba; Jerome Dumortier; Christop 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 152 KB 👁 1 views

The prevalence of renal insufficiency before and at 1, 12, and 60 months after liver transplantation (LTx; primary endpoint) and the changes in the glomerular filtration rate (GFR) at same time points according to the immunosuppressive regimen (coprimary endpoint) were investigated. The primary outc